Press Releases

All Releases
Yield10 Bioscience to Host Webcast of its 2017 Year-end Conference Call
February 28, 2018
WOBURN, Mass. , Feb. 28, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience,Inc. (NASDAQ: YTEN ) announced today that the Company plans to release its fourth quarter and full year 2017 financial results and host a conference call with management after market close on Thursday, March 8, 2018 .
Yield10 Bioscience Announces Closing of $14.5 Million Public Offering
December 21, 2017
WOBURN, Mass. , Dec. 21, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN ) today announced the closing of an underwritten public offering of units for gross proceeds of $14.5 million , which includes the full exercise of the underwriter's over-allotment option to purchase additional
Yield10 Bioscience Announces Pricing of $12.6 Million Public Offering
December 19, 2017
WOBURN, Mass. , Dec. 19, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN ) today announced the pricing of an underwritten public offering of units for gross proceeds of $12.6 million , prior to deducting underwriting discounts and commissions and offering expenses payable by Yield10
Yield10 Bioscience CSO Dr. Kristi Snell to Present at CanolaWeek 2017
December 7, 2017
WOBURN, Mass. , Dec. 07, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN ) announced that CSO Kristi Snell , Ph.D., will be presenting today on a panel being held at the CanolaWeek 2017 conference.  Dr. Snell's presentation is titled "Technology for increasing seed yield and oil
Yield10 Bioscience Announces Adjournment of Special Meeting of Stockholders
November 29, 2017
WOBURN, Mass. , Nov. 29, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN ) announced today that the Special Meeting of Stockholders scheduled for today to vote on a proposal to decrease the number of shares authorized has been adjourned to December 27, 2017 at 11:30 am ET at 19
Yield10 Bioscience Announces Third Quarter 2017 Financial Results
November 9, 2017
WOBURN, Mass. , Nov. 09, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN ) today reported financial results for the three and nine months ended September 30, 2017 . "Over the course of 2017 we have focused on generating proof points in key crops for our C3003 yield trait gene," said
Yield10 Bioscience to Host Webcast of its Third Quarter 2017 Conference Call
November 6, 2017
WOBURN,Mass., Nov. 06, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN ) announced today that the Company plans to release its third quarter 2017 financial results and host a conference call with management after market close on Thursday, November 9, 2017 .   Shareholders will
Yield10 Bioscience Announces Second Quarter 2017 Financial Results
August 10, 2017
WOBURN, Mass. , Aug. 10, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN ) today reported financial results for the three months ended June 30, 2017 . "We made solid progress in the second quarter driving toward the generation of proof points in our research and development
Yield10 Bioscience CEO Dr. Oliver Peoples to Present at BIO 2017
June 20, 2017
WOBURN, Mass. , June 20, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN ) announced that CEO Oliver Peoples , Ph.D., will be presenting today at BIO 2017 on a panel entitled: Unpredictable Weather:  How biology-based ag innovations are helping society both mitigate the causes of
Displaying 41 - 60 of 87